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The aim of this study was to evaluate the interfractional prostate motion of patients immobilized in the prone
position using a thermoplastic shell. A total of 24 patients with prostate calcifications detectable using a kilo-
voltage X-ray image-guidance system (ExacTrac X-ray system) were examined. Daily displacements of the
calcification within the prostate relative to pelvic bony structures were calculated by the ExacTrac X-ray
system. The average displacement and standard deviation (SD) in each of the left–right (LR), anterior–posterior
(AP), and superior–inferior (SI) directions were calculated for each patient. Based on the results of interfrac-
tional prostate motion, we also calculated planning target volume (PTV) margins using the van Herk formula
and examined the validity of the PTV margin of our institute (a 9-mm margin everywhere except posteriorly,
where a 6-mm margin was applied). In total, 899 data measurements from 24 patients were obtained. The
average prostate displacements ± SD relative to bony structures were 2.8 ± 3.3, −2.0 ± 2.0 and 0.2 ± 0.4 mm, in
the SI, AP and LR directions, respectively. The required PTV margins were 9.7, 6.1 and 1.4 mm in the SI, AP
and LR directions, respectively. The clinical target volumes of 21 patients (87.5%) were located within the PTV
for 90% or more of all treatment sessions. Interfractional prostate motion in the prone position with a thermo-
plastic shell was equivalent to that reported for the supine position. The PTV margin of our institute is consid-
ered appropriate for alignment, based on bony structures.
Keywords: intensity-modulated radiotherapy; interfractional prostate motion; prone position; prostate cancer;
thermoplastic shell
INTRODUCTION
Several studies have been conducted to determine whether a
supine or prone fixation position is superior for external
beam radiotherapy (EBRT) in patients with prostate cancer
[1–11]. However, the optimal treatment position for prostate
EBRT remains controversial and inconclusive because each
position has its own merits and demerits. The merit of the
prone position is that the irradiation dose to the rectum is
reduced because the seminal vesicles are pulled away from
the rectum [1, 11]. It has also been reported that the geomet-
ric relationship between the prostate and pelvic bony
anatomy is more consistent in the prone position [5], a
finding that is very important for centers that use bony-
structure-based positioning. Conversely, a demerit of the
prone position is the greater prostate motion compared with
the supine position [3, 4]. Additionally, the supine position
is more comfortable for patients and more convenient for
therapists than the prone position [3].
We have treated patients with localized prostate cancer
using intensity-modulated radiotherapy (IMRT) in the prone
position fixed with a thermoplastic shell since 2000. We
adopted the prone position for two reasons. First, the rectal
dose is reduced because we treat mainly locally advanced
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prostate cancer patients in whom the seminal vesicles are
included in the clinical target volume (CTV) [11]. Second,
we applied bony-structure-based positioning because we had
no soft-tissue-based image-guided radiotherapy (IGRT) options
when we first began using IMRT for prostate cancer. To com-
pensate for the expected large prostate motion in the prone pos-
ition, we immobilized patients by using a thermoplastic shell.
To our knowledge, only three reports have examined in-
terfractional prostate motion in the prone position when
immobilized with a thermoplastic shell [3, 12, 13]. However,
those reports did not document sufficient data with systemat-
ic and random errors to calculate the required planning target
volume (PTV) margin because they examined only three add-
itional computed tomography (CT) data measurements per
patient or assessed the lateral portal image alone. Therefore,
no report to date has determined the adequate PTV margin in
the prone position while immobilized using a thermoplastic
shell.
Beginning in 2007, we were able to use a dual-orthogonal
kilo-voltage (kV) X-ray IGRT system (ExacTrac X-ray
system; BrainLAB AG, Feldkirchen, Germany) for patient
positioning. This system also allows detection of calcifica-
tion within the prostate (Fig. 1). Because calcification in the
prostate is a reliable marker of prostate position [14], using
this IGRT system we are able to assess interfractional pros-
tate motion in all fractions without the need for an invasive
procedure, based on routinely acquired clinical data. The aim
of the present study was to evaluate interfractional prostate
motion in patients immobilized with a thermoplastic shell in
the prone position. Additionally, we validated the adequacy
of the PTV margin applied at our institute.
MATERIALS ANDMETHODS
Patients’ characteristics
Between August 2007 and August 2010, 163 consecutive
patients with localized prostate cancer (cT1c-T4N0M0)
received IMRT using Novalis (BrainLAB AG) at our
institute. Of these, the ExacTrac X-ray system clearly
detected calcification within the prostate in 24 patients. Since
all of the system’s image data for localization were stored
and accessible, we included these 24 patients in the present
analyses. The median age of the study population was 72
years (range, 59–80 years). T-stage was 17 with T1c–T2b, 3
with T2c, and 4 with T3a. The median prostate-specific
antigen (PSA) and Gleason scores were 10.55 ng/ml and 7,
respectively. Patients’ characteristics are summarized in
Table 1. Witten informed consent was obtained from the
patients to use their clinical data for research purposes and
for publication.
Radiation therapy
Each patient underwent pretreatment planning CT scans
(LightSpeed RT; GE Healthcare, Waukesha, WI, USA) of
2.5-mm slice thickness. All patients were instructed to void
the bladder and rectum about 1–1.5 h before the CT simula-
tion, according to their individual urinary conditions. In
actual treatments, patients were also required to void the
bladder and rectum at exactly the same timing as set in the
CT simulation. In addition, the treatment time was fixed by
each patient to maintain patients’ condition. Patients were
immobilized in the prone position with a thermoplastic shell
(Hip Fix system; CIVCO Medical Solutions, Kalona, IA,
USA) that extended from the mid-thigh to the upper third of
the leg, in combination with a vacuum pillow (Vac-Lok
Fig. 1. Examples of ExacTrac X-ray images. Intra-prostatic
calcifications were clearly detected (yellow circle).
Table 1. Patients’ characteristics and treatment parameters
Age (years) 59–80 (median, 72)








Initial PSA value (ng/ml) 5.03–49.00 (median, 10.55)





UICC = classification of the International Union Against Cancer,
NAHT = neoadjuvant hormonal therapy, CAB = combined
androgen blockade, PSA = prostate-specific antigen,
RT = radiotherapy.
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system; CIVCO Medical Solutions) and a leg support
(Fig. 2). Details of our planning protocol have been reported
previously [15, 16]. Briefly, the CTV consisted of the pros-
tate and seminal vesicles (base to the whole depending on
the clinical stage), not including the lymph node area. The
PTV was the CTV plus a 9-mm margin everywhere except
posteriorly, where a 6-mm margin was applied. The PTV
was treated with a dose of between 70 Gy in 35 fractions and
78 Gy in 39 fractions (median, 74 Gy). Patients were posi-
tioned based on their pelvic bone structures using the
ExacTrac X-ray system immediately before each treatment
session.
Analysis of interfractional prostate motion
Displacement of the position of a calcification within the
prostate between each daily session and the DRR image at
the CT simulation was calculated based on the ExacTrac
data. If more than one calcification was identified within the
prostate, the largest one was used to calculate the position.
The average displacement and the standard deviation (SD)
in each of the left–right (LR), anterior–posterior (AP), and
superior–inferior (SI) directions were calculated for each
patient.
Calculation of the required PTV margin
The required PTV margins were generated using the van
Herk formula (2.5Σ + 0.7σ) [17]. The Σ was calculated as the
SD of the mean displacement for each individual patient.
The σ was determined by computing the root mean square of
the SD of an individual patient’s displacements. This method
is intended to guarantee that 90% of patients receive a
minimum cumulative CTV dose of at least 95% of the
prescribed dose.
Comparison of prostate motion with other reports
and validation of the PTV margin
To validate the adequacy of the applied PTV margin, we cal-
culated the required PTV margin using the van Herk formula
to compare prostate motion with other reports, which often
report Σ and σ values [8, 18–24], because we believe that the
calculated PTV margin expresses the total possible variation
of prostate motion simply.
In addition, we generated accumulated CTV dose reflect-
ing interfractional prostate motion. This allowed estimation
of actually delivered target dose and was generated as
follows. First, isocenter-shifted plans, in which the isocenter
was shifted to compensate for the corresponding positional
error of the prostate by each fraction, were generated for
every patient. Then, all plans of the individual patient were
summed up on the Eclipse (ver. 8.6) treatment-planning
system (Varian Medical Systems, Palo Alto, CA, USA), and
the accumulated CTV dose was calculated. We assessed the
dose–volume histogram (DVH) of this accumulated CTV
dose. We also evaluated the probability of prostate motion
coverage within our clinical PTV margin.
RESULTS
In total, 899 ExacTrac X-ray system data measurements from
24 patients were available for registration of bony structures
and calcification. The average prostate displacements ± SD
relative to the bony structure were −2.0 ± 2.0, 2.8 ± 3.3 and
0.2 ± 0.4 mm, in the AP, SI and LR directions, respectively.
There was a tendency for a large shift in the SI direction, and
displacement of more than 10 mm was observed only in the
SI direction. The displacement in the LR direction was gen-
erally small.
Table 2 summarizes the means, SDs, ranges, Σ, σ and
PTV margins of interfractional prostate displacement in the
Fig. 2. Patient fixed in the prone position with the combination of a thermoplastic shell, a vacuum pillow and a leg
support.
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AP, SI and LR directions. The Σ values of the AP, SI and LR
directions were 2.0, 3.3 and 0.4 mm, respectively, and the σ
values were 1.6, 2.2 and 0.7 mm, respectively. Both Σ and σ
were also largest in the SI direction. The PTV margins calcu-
lated using the van Herk formula were 6.1, 9.7 and 1.4 mm
in the AP, SI and LR directions, respectively. The prostate
displacement of 21 patients (87.5%) was within the applied
PTV margins (9-mm margin everywhere except posteriorly,
where a 6-mm margin was applied) in 90% or more of all
treatment sessions. With regard to the DVH of the accumu-
lated CTV dose, the average mean dose ± SD and the dose at
the 95% volume level of the cumulative DVH (D95) ± SD of
the CTV were 100.7 ± 1.3% (range, 96.7–102.4%) and
96.2 ± 5.8% (range, 73.1–100.7%), respectively (Fig. 3).
DISCUSSION
Table 3 summarizes previously reported PTV margins for
interfractional organ motion errors relative to a bony struc-
ture [8, 18–24]. The data include seven studies in the supine
position without a thermoplastic shell, one in the supine pos-
ition with a thermoplastic shell, and one prone position
without a thermoplastic shell. Their calculated PTV margins
were 4.7–10.5 mm (mean, 8.0 mm), 4.0–12.0 mm (mean,
8.5 mm) and 1.4–4.5 mm (mean, 3.2 mm) in the AP, SI and
LR directions, respectively. Our results fall within the range
of those reported previously, indicating that the prostate
motion relative to the bony structure in individuals immobi-
lized in the prone position using a thermoplastic shell is com-
parable to that in the supine position.
To our knowledge, only three publications have examined
prostate motion in patients immobilized with a thermoplastic
shell in the prone position. Takayama et al. [12] reported
prostate motion using three additional CT scans in seven
patients, with or without a double-balloon rectal catheter.
The mean prostate displacements ± SD were 2.8 ± 1.8,
2.7 ± 1.8 and 1.3 ± 0.7 mm in the AP, SI and LR directions,
respectively. Zelefsky et al. [13] also reported interfractional
prostate motion in 50 patients, as determined by using three
additional CT scans. The mean prostate displacements ± SD
were − 1.2 ± 2.9, −0.5 ± 3.3 and −0.6 ± 0.8 mm in the AP, SI
and LR directions, respectively. Bayley et al. [3] examined
20 patients randomized with regard to treatment when immo-
bilized in the supine or prone position, and measured prostate
motion using the daily lateral film to compare bony land-
marks and fiducial marker positions. The mean prostate
motions ± SD in the prone position were 0.7 ± 4.0 and
0.7 ± 3.7 mm in the AP and SI directions, respectively.
Although these reports did not include Σ and σ data, which
enable calculation of the required PTV margin, the SD
results were similar to those we report here.
Compared with other reports fixed in the supine position
without any fixation devices, our study resulted in smaller
displacements in the AP direction and comparable displace-
ments in other directions (Table 3). It is reported that the
prone position without any fixation devices produced greater
prostate motion than the supine position [3, 4]. We believe
those results were mainly due to the respiratory motion of the
chest and abdomen. That is, the respiratory motion easily
affects the prostate position in the prone position because
chest and abdomen are touching the couch. In contrast, appli-
cation of a thermoplastic shell can contribute to restricting
respiratory-related movement. In addition, prostate locations
in the prone position are less influenced by rectal gas than
those in the supine position, because the rectal gas tends to
move and be stored in part of the rectosigmoid (Fig. 4). On
the other hand, rectal gas can easily push the prostate
upwards in the supine position, as indicated in Fig. 5. A
smaller displacement in the AP direction was also reported
by Khosa et al. but using the supine position and immobil-
ization with a thermoplastic shell [20]. As indicated before,
rectal gas in the supine position without fixation devices can
greatly affect the prostate position in the AP direction
Table 2. Interfractional prostate displacement
AP (mm) SI (mm) LR (mm)
Mean −2.0 2.8 0.2
Minimum −9.6 −11.2 −3.4
Maximum 6.0 15.4 4.7
Σ 2.0 3.3 0.4
σ 1.6 2.2 0.6
LR = left–right, AP = anterior–posterior, SI = superior–inferior,
+ =motion to the right/posterior/superior directions about
isocenter, Σ = the SD of the average displacement for each
individual patient, σ = the root mean square of the individual
SD.
Fig. 3. Dose–volume histograms of the accumulated CTV dose
for all patients. The acceptable CTV coverage of D95 ≥ 95% was
achieved in about 80% of the patients (n = 19).
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(Fig. 5). It is believed that the use of a thermoplastic shell in
the supine position can contribute to restriction of severe
rectal dilatation by gas because of the increased abdominal
pressure from the thermoplastic shell. To date and to our
knowledge, no study has compared prostate motion in the
same position with and without a thermoplastic shell. More
detailed studies are necessary in the future, but the use of a
thermoplastic shell probably reduces interfractional prostate
movement in the AP direction.
Our required PTV margin using the van Herk formula
(9.7, 6.1 and 1.4 mm in the SI, AP and LR directions, re-
spectively) is similar to the PTV margin of our institute.
Indeed, the CTV of 21 patients (87.5%) was within our PTV
margins for 90% or more of all treatment sessions.
Additionally, for the DVH of the accumulated CTV dose,
dose coverage of the CTV was almost satisfied. In fact, it
was reported that a 1.5-cm PTV margin had no significant
impact on the PSA control rate, but had a significantly nega-
tive impact on late rectal damage, compared with a 1.0-cm
margin [25]. Therefore, our PTV margin may be relevant as
far as fitting to the bony structure in the prone position in a
patient immobilized with a thermoplastic shell. However, to
prevent delivery of an insufficient dose to the CTV in
patients with relatively large prostate movements, it will be
necessary to shift to the prostate-based IGRT approach.
Indeed, we began to use this prostate IMRT approach in 2010.











Supine − Bylund et al. [19] 24 MVCT without M 972 7.0 4.0 3.1
Tanyi et al. [24] 14 CBCT with M 546 10.2 8.9 1.6
Nederveen et al. [21] 23 EPID with M 675 7.5 11.9 3.1
Osei et al. [23] 20 EPID with M 642 6.6 7.4 4.4
Alonso-Arrizabalaga
et al. [18]
30 ExacTrac with M 1330 10.5 12.0 4.1
O’Daniel et al. [22] 10 kV CT without M 243 10.4 8.6 2.8
Stroom et al. [30] 15 kV CT without M 240 8.3 8.2 4.0
+ Khosa et al. [20] 10 EPID with M 180 4.7 7.3 3.6
Prone − Stroom et al. [30] 15 kV CT without M 240 8.8 6.6 3.7
+ This study 24 ExacTrac with
calcification
899 6.1 9.7 1.4
CT = computed tomography, MVCT =megavoltage cone beam CT, M = fiducial marker, CBCT = cone beam CT, EPID = electronic
portal imaging device, AP = anterior-posterior; SI = superior-inferior, LR = left-right, ExacTrac = ExacTrac X-ray system,
kV = kilo-volt.
Fig. 4. An example of the impact of rectal gas on the prostate position in the prone fixation. (A) Sagittal view of
simulation CT with dose distribution curves. (B) Sagittal view of follow-up CT superimposed on dose distribution curves at
planning. Although a large amount of rectal gas exists, the prostate dose was maintained because most of the gas is located
in the rectosigmoid region of the rectum.
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The present study has the limitation that using only the
largest calcification within the prostate cannot account for
prostate rotation. However, previous study has indicated that
rotation errors are small, and rotation alignment offers only
1-2 mm advantage compared with translational shift alone
[26]. Another limitation is that the intrafractional prostate
motion was not considered. Several reports on intrafractional
prostate motion have been published to date [4, 9, 10, 27–29].
However, intrafractional prostate motion in the prone position
in those immobilized with a thermoplastic shell has not yet
been assessed. We are currently investigating intrafractional
prostate motion, and will report the data in the near future.
Compared with other reports, our results demonstrate that
the effect of immobilization with a thermoplastic shell in the
prone position is comparable to that in the supine position.
The superiority of the geometric relationship between the
prostate and pelvic bony anatomy in the prone position com-
pared with that in the supine position [5] was not determined
in the present study. However, if identical PTV margins are
necessary in both positions, the prone position may be pref-
erable due to the reduced irradiation dose to the rectum [11].
Interfractional prostate motion in those immobilized in the
prone position using a thermoplastic shell is equivalent to
that in the supine position reported elsewhere. The PTV
margin of our institute is generally appropriate when aligned
to the bony structure, although prostate-based positioning
will be required for patients with a large prostate motion.
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